Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Pembrolizumab Cyclophosphamide and Lenalidomide for Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03191981. IPD Sharing: NO. Countries: 1. Publications: 0.
Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma
ClinicalTrials.gov study NCT00088855. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00124813. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00352742. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone
ClinicalTrials.gov study NCT06561854. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma
ClinicalTrials.gov study NCT01555281. IPD Sharing: NO. Countries: 2. Publications: 0.
Carfilzomib, Cyclophosphamide, Dexamethasone in Transplant Eligible Newly Diagnosed High-risk Multiple Myeloma
ClinicalTrials.gov study NCT02217163. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00243035. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma
ClinicalTrials.gov study NCT06485076. IPD Sharing: NO. Countries: 1. Publications: 0.
Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00008229. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
ClinicalTrials.gov study NCT05231629. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective Evaluation of Taste Function In Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation
ClinicalTrials.gov study NCT03276481. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05650632. IPD Sharing: NO. Countries: 7. Publications: 0.
Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03836014. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Prospective Study Comparing DRd With VRd-lite in Elderly Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT06497738. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination
ClinicalTrials.gov study NCT06892522. IPD Sharing: YES. Countries: 5. Publications: 0.
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing
ClinicalTrials.gov study NCT07101445. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Multiple Myeloma（LB2505-0001）
ClinicalTrials.gov study NCT07399444. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT04091126. IPD Sharing: YES. Countries: 10. Publications: 0.
A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment
ClinicalTrials.gov study NCT02951117. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.